Long-Acting Antipsychotic Sampling Program In Hospitals Cleared By OIG Advisory Opinion
Executive Summary
Sample program focuses only on inpatient use and in hospitals that do not accept Prescription Drug Marketing Act-compliant trial units. By improving adherence, program could lower federal health care costs over time, Office of Inspector General suggests.